How can Medtronic improve its MiniMed insulin pumps to provide more personalized dosing recommendations?

Introduction

To improve Medtronic's MiniMed insulin pumps for more personalized dosing recommendations, we need to analyze user needs, pain points, and technological capabilities. I'll outline a strategic approach to enhance this critical medical device, focusing on user-centric improvements and data-driven personalization.

Step 1

Clarifying Questions (5 mins)

• Looking at the product context, I'm thinking about the current state of personalization in MiniMed pumps. Could you share what level of personalization is already implemented, and what specific areas we're looking to improve?

Why it matters: Determines our starting point and helps focus our efforts on unexplored areas. Expected answer: Basic personalization based on user-inputted data, looking to incorporate more real-time adaptations. Impact on approach: Would focus on advanced AI and sensor integration for real-time adjustments.

• Considering user behavior, I'm curious about the frequency and nature of user interactions with the pump. How often do users need to manually adjust their insulin doses, and what data points are they currently using to make these decisions?

Why it matters: Helps identify opportunities for automation and improved user experience. Expected answer: Users interact multiple times daily, relying on blood glucose readings and meal information. Impact on approach: Would prioritize features that reduce manual interactions and integrate more data sources.

• Thinking about external factors, I'm interested in the regulatory landscape for insulin pump innovations. What are the current FDA guidelines or restrictions on implementing AI or machine learning in insulin dosing recommendations?

Why it matters: Ensures our solutions are feasible within regulatory constraints. Expected answer: FDA has specific guidelines for AI/ML in medical devices, requiring extensive validation. Impact on approach: Would balance innovation with regulatory compliance, potentially phasing implementation.

• Considering the company's broader objectives, how does improving personalized dosing align with Medtronic's overall strategy in diabetes management? Are there any specific company goals or metrics we should keep in mind?

Why it matters: Ensures our solution aligns with company direction and resources. Expected answer: Aligns with strategy to lead in diabetes tech, aiming to improve patient outcomes and market share. Impact on approach: Would focus on solutions that demonstrate clear improvements in patient outcomes and differentiation from competitors.